PHARMAPRIM 100
- Brand: Pharmacom Labs - US
- Product Code: PHARMAPRIM 100
- Availability: In Stock
-
$95.00
ACTIVE HALF-LIFE
5-7 Days
CLASSIFICATION
Anabolic Steroid
DOSAGE
300-800 mg/week
ACNE
Yes
WATER RETENTION
Low
HBR
Perhaps
HEPATOTOXICITY
Low
AROMATIZATION
No
CARRIER OIL
Grapeseed Oil
MANUFACTURER
Pharmacom Labs - US
LAB TEST
See Document
WAREHOUSE
USA Warehouse 4
SUBSTANCE
Methenolone Enanthate
Introducing PHARMA PRIM 100 (Methenolone Enanthate), a powerful yet moderately anabolic steroid renowned for its minimal androgenic properties, offering an exceptional versatility for athletes and bodybuilders alike. Ideal for both cutting and bulking cycles, PHARMA PRIM 100 accelerates recovery and fosters the growth of lean, dense muscle mass.
First synthesized in 1960, Methenolone gained traction when Squibb Company launched its injectable form in 1962. Originally prescribed to combat muscle loss from surgeries, infections, or malnutrition, it has also been used in the treatment of osteoporosis and breast cancer, as well as helping underweight infants reach a healthy weight without adverse effects. As a derivative of dihydrotestosterone (DHT), Methenolone boasts a unique combination of weak androgenic activity and moderate anabolic effects.
A standout feature of Methenolone is its remarkable binding affinity to androgen receptors, surpassing that of testosterone, making it an effective fat-burning agent. Furthermore, it does not convert to estradiol, eliminating the risk of estrogen-related side effects like gynecomastia and water retention.
Regarded as one of the safest anabolic steroids available, Methenolone is a preferred choice for women, older athletes, and younger individuals seeking to enhance their physique with minimal side effects. While it may be mild, users can expect optimal results after a minimum of 10 weeks of consistent use, especially when stacked with other steroids. PHARMA PRIM 100 is particularly effective during cutting cycles, where the focus is on retaining muscle mass rather than excessive gains.

